ConductScience.org, home

Paper984752

In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole.

Santoro J and 2 others. Antimicrob Agents Chemother, 1976. Cited by 14 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole. Papers, record 984752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/984752

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1976
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.98
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Santoro JJ
2Kaye DD
3Levison MEM E

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Bacteroides fragilisMajor topic
ClindamycinMajor topic
ErythromycinMajor topic
LeucomycinsMajor topic
MetronidazoleMajor topic
Aminoglycosides

Source PubMed

References8

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,259,403Antibiotic susceptibility of the subspecies of Bacteroides fragilis.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/1259403PubMed
24,600,161Treatment of anaerobic bacterial infections with clindamycin-2-phosphate.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4600161PubMed
34,012In vitro susceptibility studies with josamycin and erythromycin.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/4012PubMed
41,267,432Rosamicin: in vitro activity against anaerobes and comparison with erythromycin.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/1267432PubMed
55,038,022Bactericidal activity of five antimicrobial agents against Bacteroides fragilis.J Infect Dis1972https://conductscience.org/library/papers/5038022PubMed
61,096,810Treatment of anaerobic infections with metronidazole.Antimicrob Agents Chemother1975https://conductscience.org/library/papers/1096810PubMed
71,104,555An evaluation of the carbon dioxide component in the GasPak anaerobic system.J Appl Bacteriol1975https://conductscience.org/library/papers/1104555PubMed
84,635,396Metronidazole versus anaerobes. In vitro data and initial clinical observations.Calif Med1972https://conductscience.org/library/papers/4635396PubMed

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
708,027In vitro susceptibility of 30 strains of Chlamydia trachomatis to rosamicin.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/708027PubMed
697,353In vitro activity of rosamicin and erythromycin against a group of nonfermenting gram-negative bacilli.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/697353PubMed
475,368In vitro susceptibility of Ureaplasma urealyticum to rosaramicin.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/475368PubMed
363,399Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use.Drugs1978https://conductscience.org/library/papers/363399PubMed
228,593Activity of semisynthetic penicillins and synergism with mecillinam against Bacteroides species.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/228593PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/984752

GET https://conductscience.org/api/papers/v1/984752/authors